West Lothian man's back pain dismissed as 'wear and tear' was incurable cancer
Our community members are treated to special offers, promotions and adverts from us and our partners. You can check out at any time. More info
A West Lothian man unknowingly climbed Ben Nevis with a broken back and incurable blood cancer.
Harry Cartmill, a local councillor for Bathgate, scaled Scotland's highest mountain while putting up with severe back pain - which had earlier been dismissed as wear and tear which he was given painkillers for.
However, it then emerged the pain was actually due to Harry having two broken vertebrae which was then diagnosed as Myeloma.
Harry completed the hike in 2019 for a fourth time, reports the West Lothian Courier. Being 53 at the time, he admitted his back pain was 'bothering him' as he struggled on the way down.
He is now raising awareness of the condition in the lead-up to Myeloma Awareness Week to ensure patients receive an early diagnosis. Despite being the third most common type of blood cancer, myeloma is frequently missed.
Symptoms including back pain, easily broken bones, fatigue and recurring infection, are vague and often linked to general ageing or minor conditions.
Harry said: "I've had two stem cell transplants and there have been hard times but I'm still here six years later. Not only still here but still living life to the full.
(Image: Myeloma UK)
"If something doesn't feel right, mention it. Get it checked. Less than two months before diagnosis I climbed Ben Nevis. I was an amateur athlete, so having a bit of pain didn't stop me. But my back was bothering me when I did it, I was really struggling on the way down.
"I used to walk up Ben Nevis like it didn't exist and I thought, 'It must be old age kicking in'. Of course it was nothing to do with that."
Harry has since lost two inches in height after doctors drilled into his hip before his diagnosis. As an avid golfer and climber, he had initially put his pain down to ageing and "wear and tear."
Prescribed painkillers, he realises the shooting pain was unlike any he'd felt before and was in a different part of his back, which should have raised the alarm with his GP.
Harry continued: "I'd had great health my whole life. When you push yourself, climbing mountains, or cycling 100 miles and running half marathons, you're used to a bit of pain.
"I went to the doctor and he told me to take it easy, cut back on the golf, take painkillers. He said I was getting a bit older. But the pain progressively got worse. I think there needs to be an awareness there for some GPs. Not everybody with a pain in their spine has been overdoing it in the garden or playing too much golf.
"The last week-and-a-half before I was diagnosed, I was really struggling. I knew something was wrong. I knew it wasn't just Father Time catching up with me. But I never thought it could be myeloma."
Another GP at his practice, realised something was wrong and sent Harry for an X-ray, which showed he had two broken vertebrae. He was quickly diagnosed with myeloma.
Join Edinburgh Live's Whatsapp Community here and get the latest news sent straight to your messages
Harry continued: "When they saw the broken bones, they asked me if I'd had some kind of trauma, if I had fallen off my bike. So that rang alarm bells. A day or two later they drilled into my hip and that's when the diagnosis of myeloma came. I used to be almost 6ft and now I'm just over 5ft 9in. My spine is not as straight as it once was."
Harry started chemotherapy and later received a stem cell transplant.
"The treatment was incredibly hard," Harry admits. "I was a skeleton who could barely walk up the stairs."
Unfortunately, Harry's cancer returned after just 18 months and he underwent chemotherapy again, followed by a second stem cell transplant. Two years on he is still in remission and determined to live a full life.
He attended his daughter's wedding in May and last year celebrated a year in remission and his dog's 12th birthday by climbing Tinto Hill.
"When you get a second chance, or a third chance as I was given, you have to make the best of every day with your family, your friends, your pets," said Harry.
"I'm 60 at the start of next year and that would be a great milestone to reach, and I'm hoping that I can, because when I was diagnosed I didn't think I would get to that. I'm lucky to be alive."
Dr Sophie Castell, Chief Executive at blood cancer charity Myeloma UK, said: We know that myeloma can be difficult to diagnose, so bring the Myeloma UK Symptom Translator with you to the GP, ask for answers and get to the bottom of what's causing your pain, infections or fatigue."
For more information about myeloma or to download the symptom translator visit: myeloma.org.uk/signs. Myeloma UK also run an Infoline, call 0800 980 3332.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
3 hours ago
- BBC News
Cancer: World-first 'Trojan horse' therapy to be given on NHS
A "Trojan horse" therapy that sneaks toxic drugs inside cancer cells is being made available on the NHS in England in a world can halt the blood cancer myeloma for nearly three times longer than current drug is an advanced form of chemotherapy that hits cancer with a bigger dose, while reducing Silvester, one of the first people to get it, says the therapy has been "life-changing" and he's now planning history-themed adventures. Myeloma – also known as multiple myeloma – affects part of the immune system called plasma cells. These are made in the spongey bone marrow in the centre of our who is 60 and from Sheffield, was diagnosed nearly two years ago after the cancer led to broken bones in his had a bone marrow transplant last year, but relapsed around Christmas. He has since been on the new therapy – called belantamab mafodotin – as part of an early access weeks he was in remission. Other treatments could have left him isolating in his bedroom for months, so Paul says the therapy "is absolutely life-changing" and was "creating that opportunity to enjoy" life. Visiting Hadrian's Wall is next on the agenda for history buff Paul; and he's looking forward to one of his daughters graduating later this year. "Most people say 'you look really really well'... I have a good normal life," he told the BBC. How does this therapy work? Paul's therapy - belantamab mafodotin – is a lethal chemotherapy drug that has been bound to an antibody, similar to the ones the body uses to fight infection. However, these antibodies have been designed to spot markings on the outside of plasma cells. So they travel to cancerous cells, stick to the surface and are then absorbed. Once inside they release their toxic payload, to kill the cancer. The therapy is named Trojan horse therapy after the siege of the city of Troy in Greek mythology, when a giant wooden horse was used to smuggle soldiers into the cannot be cured, but clinical trials last year showed the Trojan horse therapy halted the cancer for three years, compared to 13 months with current therapies. Prof Peter Johnson, the national clinical director for cancer at NHS England, said the difference was "life-changing".He told me: "This is a really important development for people with myeloma, because although we may not be able to cure the illness, giving them time free of the disease and free of the symptoms is really important."We've seen in the last few years that using antibodies to deliver chemotherapy drugs directly into cells can make a big difference for a variety of different types of cancer." Around 33,000 people are living with myeloma in the UK. The new drug will be used when the first-choice therapy fails, so around 1,500 patients a year could decision comes after a review by the National Institute of Health and Care Excellence (NICE) concluded the drug was cost-effective for NHS use. NICE recommendations are normally adopted in England, Wales and Northern Ireland while Scotland has its own process. The therapy is kinder than other cancer treatments, but is not free from side-effects. After a cancer cell has been destroyed, the remaining chemotherapy drug will leak into the body. This can cause dry eyes and blurred vision. 'These are very smart drugs' The technical name for these drugs is an therapy was developed by GSK in the UK with early research taking place in Stevenage and the first clinical trials in Martin Kaiser, team leader in myeloma molecular therapy at the Institute of Cancer Research, said these "are very smart drugs" and the difference in side effects compared to other drugs "is really remarkable".While myeloma is still considered an incurable cancer, Prof Kaiser says drugs like this are "an important step towards a functional cure" and he thinks long-term remission will go "above 50% in the next five years".Antibody drug conjugates are being developed for a range of cancers. The limitation is being able to design an antibody that can target the cancer alone. There is one that can target some types of breast cancer. Research is already taking place on stomach and bowel McKinlay, from the charity Myeloma UK, said the approval would "transform the lives of thousands" and it was "fantastic to see the UK at the forefront of myeloma treatment".Health Minister Karin Smyth, said: "This ground-breaking therapy puts the NHS at the forefront of cancer innovation."
The Independent
5 hours ago
- The Independent
NHS green lights ‘Trojan horse' treatment that attacks cancer cells from inside
Blood cancer patients in England are set to be among the first in the world to access a pioneering "Trojan horse" treatment, health officials have announced. The targeted therapy, belantamab mafodotin, also known as Blenrep, has shown promising results in halting the progression of myeloma for nearly three times as long as current treatments, according to studies. Approximately 1,500 patients annually with multiple myeloma, an incurable bone marrow cancer, are expected to benefit from this new treatment. The National Institute for Health and Care Excellence (Nice) has approved Blenrep, manufactured by GlaxoSmithKline, for use within the NHS. NHS England has confirmed that it will be the first health system worldwide to roll out the treatment. The drug will be available to patients whose cancer has advanced or has not responded to initial treatments. Administered as an infusion every three weeks alongside other cancer drugs, this antibody drug targets and attaches to cancer cells. It has been dubbed a 'Trojan horse' treatment because it works by being taken into a cancer cell, before releasing a high concentration of a lethal molecule to destroy the cell from inside. 'Myeloma is an aggressive type of blood cancer, but we have seen a steady improvement in the outlook for patients over recent years as we have introduced new targeted therapies,' Professor Peter Johnson, NHS England's national clinical director for cancer, said. 'I am delighted that patients in England will be the first to benefit from this new treatment, which has the potential to keep cancer at bay for years longer, giving people the chance of more precious time with friends and family. 'This treatment could be life-changing for many patients and their families, and that's why it is so important that the NHS continues to secure quick access to the latest, innovative treatments like this, at affordable prices to the taxpayer.' Helen Knight, director of medicines evaluation at Nice, said: 'We're delighted that people in the UK will become among the first in the world to access belantamab mafodotin for this indication. 'This recommendation demonstrates our commitment to getting the best care to patients fast, while ensuring value for the taxpayer.' Trials have suggested that the treatment, in combination with bortezomib and dexamethasone, delayed progression of the disease by an average of three years, compared to just over a year for patients taking commonly-used drug daratumumab along with the other treatments. Patient Paul Silvester, 60, from Sheffield, was diagnosed with myeloma in July 2023 and received treatment at the Royal Hallamshire Hospital. The first treatment he was given failed to stop his cancer from progressing so he was given belantamab mafodotin through an early access programme. 'I feel like this treatment has brought the party balloons back in the house. It has been amazing – within the first two or three weeks, after the first dose, I was in remission,' he said. 'It gives me quite a lot of confidence in the drugs and it makes me more optimistic about the future. 'I've been feeling well and I'm still quite active – that's what's important in terms of your quality of life. 'One of my daughters is graduating from university in October and it's a goal for me to be there.' Shelagh McKinlay, director of research and advocacy at blood cancer charity Myeloma UK, said: 'It's fantastic to see the UK at the forefront of myeloma treatment. 'We have been working very hard for the last year to get this treatment approved and we know it will transform the lives of thousands of people with myeloma.' Health Minister Karin Smyth said: 'This groundbreaking therapy puts the NHS at the forefront of cancer innovation. 'By harnessing cutting-edge 'trojan horse' technology, we're offering new hope to blood cancer patients across the country.'
Daily Mail
a day ago
- Daily Mail
Ambulance call-outs to deal with prison overdoses soar amid 'drugs epidemic'
The number of ambulance call-outs made to prisons after reported overdoses and 'poisonings' has almost doubled in the past year, fuelling fears of a 'drug epidemic' behind bars. New Scottish Ambulance Service (SAS) figures show that 109 calls were made in 2023-24, a sharp increase on the 62 calls in 2022-23 – a rise of 76 per cent. Prison bosses insisted they are working with police to 'prevent illicit substances entering our establishments, to protect people from the harm they cause'. The figures came as a group which receives taxpayers' money claimed free needles and vapes should be handed out to prisoners so they can take Class A drugs in a safer way. Last night Scottish Tory justice spokesman Liam Kerr said: 'This shocking rise in ambulance call-outs for overdoses and poisonings in prisons confirms what staff have been warning about for years. 'The drugs epidemic inside Scotland's jails is escalating, putting inmates' lives at risk, creating a toxic atmosphere for those trying to get clean and putting prison officers in danger. 'It's also adding to the strain on our already overstretched emergency workers - at a time when Scotland's ambulance service is unable to meet demand, these additional, avoidable pressures are making things worse.' Among the prisons with the highest number of ambulance call-outs for 'overdose/poisoning' since 2019 were HMP Shotts (65) in Lanarkshire and HMP Addiewell in West Lothian (47). A further 45 calls were made to HMP Glenochil [in Tullibody, Clacks], 42 at HMP Barlinnie in Glasgow, 38 at HMP Grampian, 23 at HMP Perth. Meanwhile, the Scottish Drugs Forum - which received almost £2million from the public purse last year - has suggested the Scottish Prison Service (SPS) should provide drug paraphernalia so inmates can inject narcotics in prison. That is despite guards battling a drug crisis as more than a third of inmates have admitted taking illegal substances in prison, with more than a quarter saying their drug use only started - or increased - while in custody. The Forum's plan came after Health Secretary Neil Gray last week said a heroin shooting gallery in Glasgow may be extended to allow addicts to inhale crack cocaine. Commenting further on the ambulance call-outs last night, Tory MSP Mr Kerr said: 'Nationalist ministers, detached from reality in their Holyrood bubble, have allowed this situation to spiral out of control. 'There are solutions to this problem if the Scottish Government would only put in the time, effort and resource to examine and implement them.' An SPS spokesman said: 'The health and wellbeing of those in our care is a key priority. 'We work with NHS partners, who are responsible for healthcare in our establishments, to ensure emergency calls to the SAS are only made when necessary and appropriate. 'Our staff work hard, alongside partners, including Police Scotland, to prevent illicit substances entering our establishments, to protect people from the harm they cause.' A Scottish Government spokesman said: 'The SPS are managing a high and complex prison population and work closely with Police Scotland and other justice partners to prevent the availability and supply of illicit substances. 'This includes SPS piloting the introduction of grilles on windows in HMP Perth, HMP Edinburgh, and HMP Glenochil to prevent items being passed from drone to an individual in a cell. 'If successful, this pilot will be expanded where appropriate. 'The NHS, which is responsible for healthcare in prisons, works closely with the SPS to ensure emergency calls to the Scottish Ambulance Service are only made when necessary and appropriate. 'We are also increasing investment in our vital prison service by increasing the SPS resource budget by 10 per cent to £481.5million in 2025/26, which helps promote the health, safety, and wellbeing of all people who live in Scotland's prison system.'
